ArticleCancer communications (London, England)2022

Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool.

Nicolas A Fraunhoffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.